Atara Biotherapeutics, Inc. License Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to First Amended and Restated Exclusive License Agreement between Atara Biotherapeutics, Inc. and Memorial Sloan Kettering Cancer Center
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2025
Fourth Amended and Restated Exclusive License Agreement between The Council of the Queensland Institute of Medical Research and Atara Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2022
First Amendment to Third Amended and Restated License Agreement between Atara Biotherapeutics, Inc. and Council of the Queensland Institute of Medical Research
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
NY
2021
Research, Development and License Agreement between Bayer AG and Atara Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
NY
2021
Third Amended and Restated Exclusive License Agreement between The Council of the Queensland Institute of Medical Research and Atara Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2020
Second Amended and Restated Exclusive License Agreement between The Council of the Queensland Institute of Medical Research and Atara Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2019
Amendment No. 1 to Exclusive License Agreement between Memorial Sloan Kettering Cancer Center and Atara Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2019
Amended and Restated Exclusive License Agreement between The Council of the Queensland Institute of Medical Research and Atara Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2018
Exclusive License Agreement between Memorial Sloan Kettering Cancer Center and Atara Biotherapeutics, Inc. for EBV/CMV and WT1 Specific T-Cell Technology
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
NY
2015
Exclusive License Agreement between Amgen Inc. and Santa Maria Biosciences, Inc. (September 7, 2012)
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2014
Exclusive License Agreement between Amgen Inc. and Pinta Biosciences, Inc. (September 7, 2012)
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2014
Exclusive License Agreement between Amgen Inc. and Nina Biosciences, Inc. (September 7, 2012)
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2014
Amendment No. 3 to Exclusive License Agreement between Amgen Inc. and Santa Maria Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 2 to Exclusive License Agreement between Amgen Inc. and Santa Maria Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 1 to Exclusive License Agreement between Amgen Inc. and Santa Maria Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Exclusive License Agreement between Amgen Inc. and Santa Maria Biosciences, Inc. (September 7, 2012)
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2014
Amendment No. 2 to Exclusive License Agreement between Amgen Inc. and Pinta Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 1 to Exclusive License Agreement between Amgen Inc. and Pinta Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Exclusive License Agreement between Amgen Inc. and Pinta Biosciences, Inc. (September 7, 2012)
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2014
Amendment No. 2 to Exclusive License Agreement between Amgen Inc. and NINA Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 1 to Exclusive License Agreement between Amgen Inc. and Nina Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Exclusive License Agreement between Amgen Inc. and Nina Biosciences, Inc. (September 7, 2012)
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2014